| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 11/11/2016 | Cardiff Oncology, Inc. | TROV | Purchase | Common Stock, $.0001 par value per share | 322.5k | $3.08 | $993.2k | See footnotes | 11/11/2016 |
| 11/18/2015 | RESPONSE GENETICS INC | RGDX | Disposition | Common Stock, $0.01 par value per share | 2.8M | $0.00 | $0 | See footnotes | 11/18/2015 |
| 11/18/2015 | RESPONSE GENETICS INC | RGDX | Disposition | Common Stock, $0.01 par value per share | 1.8M | $0.00 | $0 | See footnotes | 11/18/2015 |
| 11/17/2015 | RESPONSE GENETICS INC | RGDX | Disposition | Common Stock, $0.01 par value per share | 232.9k | $0.00 | $0 | See footnotes | 11/13/2015 |
| 11/17/2015 | RESPONSE GENETICS INC | RGDX | Disposition | Common Stock, $0.01 par value per share | 147.1k | $0.00 | $0 | See footnotes | 11/13/2015 |
| 11/16/2015 | RESPONSE GENETICS INC | RGDX | Disposition | Common Stock, $0.01 par value per share | 183.9k | $0.00 | $0 | See footnotes | 11/13/2015 |
| 11/16/2015 | RESPONSE GENETICS INC | RGDX | Disposition | Common Stock, $0.01 par value per share | 116.1k | $0.00 | $0 | See footnotes | 11/13/2015 |
| 11/13/2015 | RESPONSE GENETICS INC | RGDX | Disposition | Common Stock, $0.01 par value per share | 47.9k | $0.00 | $0 | See footnotes | 11/13/2015 |
| 11/13/2015 | RESPONSE GENETICS INC | RGDX | Disposition | Common Stock, $0.01 par value per share | 547.1k | $0.00 | $0 | See footnotes | 11/13/2015 |
| 11/11/2015 | RESPONSE GENETICS INC | RGDX | Disposition | Common Stock, $0.01 par value per share | 30k | $0.00 | $0 | See footnotes | 11/10/2015 |
| 11/10/2015 | RESPONSE GENETICS INC | RGDX | Disposition | Common Stock, $0.01 par value per share | 60k | $0.00 | $0 | See footnotes | 11/10/2015 |
| 07/17/2015 | Cardiff Oncology, Inc. | TROV | Purchase | Common Stock, $0.0001 par value per share | 140k | $8.75 | $1.2M | See footnotes | 07/17/2015 |
| 04/03/2015 | RESPONSE GENETICS INC | RGDX | Other (acquisition) | Warrants (right to buy) | 1.4M | $0.37 | $500k | See footnotes | 04/03/2015 |
| 04/02/2015 | Cardiff Oncology, Inc. | TROV | Purchase | Common Stock, $.0001 par value per share | 300k | $6.90 | $2.1M | See footnotes | 04/02/2015 |
| 02/27/2015 | Cardiff Oncology, Inc. | TROV | Purchase | Common Stock, $.0001 par value per share | 79.3k | $5.62 | $445.9k | See footnotes | 02/25/2015 |
| 02/26/2015 | Cardiff Oncology, Inc. | TROV | Purchase | Common Stock, $.0001 par value per share | 78.8k | $5.42 | $427.1k | See footnotes | 02/25/2015 |
| 02/25/2015 | Cardiff Oncology, Inc. | TROV | Purchase | Common Stock, $.0001 par value per share | 105.1k | $5.12 | $538.3k | See footnotes | 02/25/2015 |
| 02/06/2015 | Cardiff Oncology, Inc. | TROV | Purchase | Common Stock, $.0001 par value per share | 444.4k | $4.50 | $2M | See footnotes | 02/06/2015 |
| 09/13/2012 | RESPONSE GENETICS INC | RGDX | Purchase | Common Stock, par value $.01 per share | 3M | $1.10 | $3.3M | See footnotes | 09/13/2012 |
| 10/08/2009 | SYNAGEVA BIOPHARMA CORP | GEVA | Sale | Common Stock, par value $.001 per share | 2.1M | $3.53 | $7.6M | See footnotes | 10/08/2009 |
| 12/12/2008 | ORCHID CELLMARK INC | ORCH | Purchase | Common Stock, par value $.001 per share | 915.1k | $0.65 | $594.8k | See footnotes | 12/12/2008 |
| 04/14/2008 | Jazz Pharmaceuticals plc | JAZZ | Purchase | Common Stock, par value $.0001 per share | 9.9k | $8.47 | $84.2k | See footnotes | 04/14/2008 |
| 04/11/2008 | Jazz Pharmaceuticals plc | JAZZ | Purchase | Common Stock, par value $.0001 per share | 10.7k | $8.45 | $90.6k | See footnotes | 04/11/2008 |
| 04/10/2008 | Jazz Pharmaceuticals plc | JAZZ | Purchase | Common Stock, par value $.0001 per share | 2.5k | $8.50 | $20.9k | See footnotes | 04/10/2008 |
| 04/08/2008 | Jazz Pharmaceuticals plc | JAZZ | Purchase | Common Stock, par value $.0001 per share | 300 | $8.48 | $2.5k | See footnotes | 04/08/2008 |
| 04/07/2008 | Jazz Pharmaceuticals plc | JAZZ | Purchase | Common Stock, par value $.0001 per share | 26.8k | $8.66 | $232.5k | See footnotes | 04/07/2008 |
| 04/04/2008 | Jazz Pharmaceuticals plc | JAZZ | Purchase | Common Stock, par value $.0001 per share | 1.5k | $8.74 | $13.1k | See Footnotes | 04/04/2008 |
| 04/03/2008 | Jazz Pharmaceuticals plc | JAZZ | Purchase | Common Stock, par value $.0001 per share | 7.4k | $8.75 | $65.2k | See footnotes | 04/03/2008 |
| 04/02/2008 | Jazz Pharmaceuticals plc | JAZZ | Purchase | Common Stock, par value $.0001 per share | 40.8k | $8.74 | $356.4k | See footnotes | 04/02/2008 |
| 03/14/2008 | Jazz Pharmaceuticals plc | JAZZ | Purchase | Common Stock, par value $.0001 per share | 1 | $9.48 | $9.5 | See footnotes | 03/14/2008 |
| 08/21/2007 | SYNAGEVA BIOPHARMA CORP | GEVA | Purchase | Common Stock, par value $.001 per share | 10.1k | $7.00 | $70.6k | See footnotes | 08/20/2007 |
| 08/20/2007 | SYNAGEVA BIOPHARMA CORP | GEVA | Purchase | Common Stock, par value $.001 per share | 31.9k | $7.07 | $225.5k | See footnotes | 08/20/2007 |